Insight

Hind Rafei: Brief Updates on CAR-Natural Killer Cell Therapy for Cancer

Hind Rafei and Katy Rezvani

Dec 9, 2024, 13:23

Hind Rafei: Brief Updates on CAR-Natural Killer Cell Therapy for Cancer

Hind Rafei, Assistant Professor in the Department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center, shared a recent article on X:

“Please check out our recent in a Nutshell article for brief updates on CAR-Natural killer cell therapy for cancer.

Lots of new exciting frontiers in the field.”

Title: Advances and challenges in chimeric antigen receptor-natural killer cell immunotherapy for cancer

Authors: Hind Rafei and Katayoun Rezvani

More posts featuring Hind Rafei.

antigen receptor British Journal of Haematology cancer Hind Rafei immunotherapy Journal of Haematology Katayoun Rezvani MD Anderson Cancer Center Natural Killer cell OncoDaily Oncology Stem Cell Transplantation therapy

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage